Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cell Therapy in Dilated Cardiomyopathy
NCT00333827Phase 3Completed
- Sponsor
- Ministry of Health
- Start
- Jan 2006
- Primary completion
- Dec 2012
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of autologous bone marrow stem cells in dilated cardiomyopathy (DCM) (2 arms), sponsored by Ministry of Health. Primary endpoint: Left Ventricle Ejection Fraction at 6 months. Started Jan 2006; status: completed.
02
Drugs
autologous bone marrow stem cells
03
Conditions
dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on NCT00333827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00333827.